Frank E. Thomas - 01 Jun 2022 Form 4 Insider Report for Orchard Therapeutics plc

Reporting relationship: Title: President & Chief Operating Officer
Issuer ticker: N/A
Reported as of: 01 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jun 2022, 08:00:15 UTC
Prior SEC filing: 12 May 2022
Next SEC filing: 19 Sep 2022
Source filing: View source filing
Reporting owner signature: /s/ Frank Thomas

Key filing fact

Frank E. Thomas filed Form 4 for Orchard Therapeutics plc on 03 Jun 2022.

Key facts

This page summarizes Frank E. Thomas's Form 4 filing for Orchard Therapeutics plc.
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Jun 2022, 08:00.

Change

Previous filing in this sequence was filed on 12 May 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ORTX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +375,000
Change %
Price: $0.000000
Shares after: 375,000
Date: 01 Jun 2022
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 375,000
Exercise price: $0.4591
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares subject to this option shall vest and become exercisable in twenty-four (24) equal monthly installments, with the first installment vested on March 1, 2022.

Footnote F2

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

SEC remarks

Title: President & Chief Operating Officer